Abstract
ObjectiveThe comparative crude death rates (CDR) among non-vitamin K antagonist oral anticoagulants (NOACs) are unknown. Further, whether NOACs improve survival when compared with warfarin is also unclear. We compared CDR...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have